Rheumatoid arthritis

Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients

Arthritis Res TherPublished Retrospective cohort study

Authors' conclusion

The application of a temporal criterion allowed for the selection of a subgroup of pD2T-RA patients who differ from those who meet the definition of D2T-RA only episodically. Chronic use of glucocorticoids was the factor most strongly associated with pD2T-RA status.

Study context

Population
Adult RA patients in a single-centre real-life cohort; 104 refractory to ≥ 2 treatments104 refractory to ≥ 2 treatments
Participants
610 patients
Exposure
Persistent D2T-RA vs D2T-RA met only episodically
Outcome
Prevalence of D2T-RA at each timepoint and persistence (pD2T-RA) over 12 months
Follow-up
12 months
Methodological detailssingle-centre, real-life cohort, bimonthly assessment over previous 12 months, logistic regression
  • Single-centre
  • Real-life cohort
  • Bimonthly assessment over previous 12 months
  • Logistic regression

Main finding

As reported in the abstract

Prevalence of D2T-RA among refractory patients

Observational data: associations, not effects.

Further findings

Characteristics associated with persistent D2T-RA (pD2T-RA)

Associated with male gender, higher HAQ and Charlson Comorbidity Index scores, more failed treatments, and use of non-NSAID analgesics
Logistic regression: linked to higher SDAI and CRP values, and use of GC or analgesics
Chronic GC use strongly associated with pD2T-RA

Original publication

Truth unveiled by time and the marbled definition of D2T-RA: retrospective analysis on the persistence of the difficult-to-treat status among refractory RA patients. Arthritis Res Ther. Published 17 September 2024. doi:10.1186/s13075-024-03390-x

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.